HIV/AIDS RETROVIRAL DRUGS
November 1st, 2003
BY KEITH NUTHALLUNITED Nations secretary general Kofi Annan has welcomed an agreement between the (former US President) Clinton Foundation and four pharmaceutical companies in developing countries to halve the price of anti-retroviral drugs treating HIV/AIDS. Aspen Pharmacare Holdings, of Johannesburg, South Africa; Cipla of Mumbai, India; Ranbaxy Laboratories, of Delhi, India; and Matrix Laboratories of Hyderabad, India, will cut the annual cost of drugs for each infected person to as little as US$140. Annan said he hoped the initiative would encourage other ...
Full access to this article can be arranged with permission from the client that first ordered it. Please contact us to request access. Entries are uploaded to our archive at least one year after being published by a client – free access is restricted to International News Services journalists for background research only. The article date indicates when copy was filed to a client, not when posted to this archive. Upon client requests, International News Services will remove such articles from the archive or not upload them in the first place. They are included to demonstrate the breadth of topics undertaken by the agency and also to help promote clients’ coverage.